Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease.

Sandhir R, Mehrotra A.

Biochim Biophys Acta. 2013 Mar;1832(3):421-30. doi: 10.1016/j.bbadis.2012.11.018.

Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease.

Abada YS, Nguyen HP, Schreiber R, Ellenbroek B.

PLoS One. 2013 Jul 11;8(7):e68584. doi: 10.1371/journal.pone.0068584.

Huntington disease: How many repeats does it take?

Hogarth P.

Neurology. 2013 May 28;80(22):e241-3. doi: 10.1212/WNL.0b013e3182984b31. No abstract available.

The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.

Youssov K, Dolbeau G, Maison P, Boissé MF, Cleret de Langavant L, Roos RA, Bachoud-Lévi AC.

Mov Disord. 2013 Dec;28(14):1995-2001. doi: 10.1002/mds.25678.

Molecule of the month: miRNA and Huntington's disease (HD).

Shapshak P.

Bioinformation. 2013 Jun 29;9(11):549-50. doi: 10.6026/97320630009549. No abstract available.

Chorea, convulsive seizures and cognitive impairment in a patient with autoimmune thyroid disease.

Kamińska A, Kamiński M, Nowaczewska M, Książkiewicz B, Junik R.

Neurol Sci. 2013 Feb;34(2):263-4. doi: 10.1007/s10072-012-0990-4. No abstract available.

Chorea, a little-known manifestation in systemic lupus erythematosus: short literature review and four case reports.

Torreggiani S, Torcoletti M, Cuoco F, Di Landro G, Petaccia A, Corona F.

Pediatr Rheumatol Online J. 2013 Oct 16;11(1):36. doi: 10.1186/1546-0096-11-36.

Bilateral basal ganglia lesions in end-stage kidney disease presenting as acute chorea.

Kuppachi S, Lwin L, Yoo J, Suneja M.

Clin Kidney J. 2013 Aug;6(4):450-1. doi: 10.1093/ckj/sft073. No abstract available.

Oral and dental health in Huntington's disease - an observational study.

Saft C, Andrich JE, Müller T, Becker J, Jackowski J.

BMC Neurol. 2013 Sep 3;13:114. doi: 10.1186/1471-2377-13-114.

Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model.

Harrison DJ, Busse M, Openshaw R, Rosser AE, Dunnett SB, Brooks SP.

Exp Neurol. 2013 Oct;248:457-69. doi: 10.1016/j.expneurol.2013.07.014.

Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.

Nithianantharajah J, Hannan AJ.

Neuroscience. 2013 Oct 22;251:66-74. doi: 10.1016/j.neuroscience.2012.05.043. Review.

Large genetic animal models of Huntington's Disease.

Morton AJ, Howland DS.

J Huntingtons Dis. 2013;2(1):3-19. doi: 10.3233/JHD-130050. Review.

Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

Valencia A, Sapp E, Kimm JS, McClory H, Reeves PB, Alexander J, Ansong KA, Masso N, Frosch MP, Kegel KB, Li X, DiFiglia M.

Hum Mol Genet. 2013 Mar 15;22(6):1112-31. doi: 10.1093/hmg/dds516.

Clinical neurogenetics: huntington disease.

Bordelon YM.

Neurol Clin. 2013 Nov;31(4):1085-94. doi: 10.1016/j.ncl.2013.05.004. Review.

Juvenile Huntington's disease: a population-based study using the General Practice Research Database.

Douglas I, Evans S, Rawlins MD, Smeeth L, Tabrizi SJ, Wexler NS.

BMJ Open. 2013 Apr 3;3(4). pii: e002085. doi: 10.1136/bmjopen-2012-002085.